Metanova Labs: Bittensor revolutionizes drug discovery with decentralized virtual screening, combinatorial reactions expand possibilities to 65 billion, and dual incentives drive innovation | TWIST

Metanova Labs is revolutionizing drug discovery by using Bittensor's decentralized AI network to screen billions of molecules efficiently. The platform utilizes combinatorial reactions to expand screening possibilities to 65 billion compounds and implements dual incentive mechanisms to drive innovation in pharmaceutical research.